Cidara Therapeutics Inc (NASDAQ:CDTX)
| 1.89 Delayed Data As of 4:00pm ET |  -0.09 / -4.55%Today’s Change | 0.40 Today|||52-Week Range 2.10 | +149.90% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 461.0K | 732.0K | 667.0K | 523.0K | ||
| Operating Expenses | Gross Income | -461.0K | -732.0K | -667.0K | -523.0K | |
| General Expenses | 31.9M | 47.7M | 55.1M | 62.8M | ||
| Research And Development | 23.5M | 35.7M | 42.8M | 49.1M | ||
| Total Operating Expenses | 32.3M | 48.4M | 55.7M | 63.3M | ||
| Non-Operating Expenses | Operating Income | -32.3M | -48.4M | -55.7M | -63.3M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 3.9M | ||
| Interest Expense On Debt | 0.00 | 22.0K | 7.0K | -- | ||
| Other Expenses | 0.00 | 0.00 | 0.00 | -211.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -32.2M | -48.2M | -55.7M | -59.0M | |
| Net Income | -32.2M | -48.2M | -55.7M | -69.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 9.9M | 14.5M | 17.5M | 25.1M | |
| Shares To Calculate EPS Diluted | 9.9M | 14.5M | 17.5M | 25.1M | ||
| Earnings Per Share | EPS | -$3.25 | -$3.32 | -$3.18 | -$2.76 | |
| EPS Diluted | -$3.25 | -$3.32 | -$3.18 | -$2.76 | ||
